Fu‐Fei Hsu
Impact in
-
- Immunotherapy and Immune Responses
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Signaling Pathways in Disease 2
- RNA Interference and Gene Delivery 2
- Advanced biosensing and bioanalysis techniques 1
-
- Phagocytosis and Immune Regulation 3
- Co-authors
- Yunching Chen (6 shared papers)Yun‐Chieh Sung (4 shared papers)Hsi‐Chien Huang (4 shared papers)Yi-Hung Ou (1 shared paper)Sheau-Yann Shieh (1 shared paper)Han‐Chung Wu (6 shared papers)Jian‐Tai Qiu (2 shared papers)Kuan‐Wei Huang (2 shared papers)
- Journals
- Journal of Biomedical Science (3 papers)Hepatology (1 paper)The EMBO Journal (1 paper)Molecular Pharmaceutics (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- TaiwanSingaporeUnited States
In The Last Decade
Fu‐Fei Hsu
15 papers receiving 632 citations
Peers
Comparison fields: 5 of 91
- Immunology 161
- Biomaterials 81
- Hepatology 42
- Infectious Diseases 87
- Molecular Biology 316
Countries citing papers authored by Fu‐Fei Hsu
This map shows the geographic impact of Fu‐Fei Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu‐Fei Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu‐Fei Hsu more than expected).
Fields of papers citing papers by Fu‐Fei Hsu
This network shows the impact of papers produced by Fu‐Fei Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu‐Fei Hsu. The network helps show where Fu‐Fei Hsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fu‐Fei Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 213 | |
| 2 | 2022 | 94 | |
| 3 | 2007 | 89 | |
| 4 | 2017 | 43 | |
| 5 | 2021 | 39 | |
| 6 | 2018 | 31 | |
| 7 | 2016 | 31 | |
| 8 | 2020 | 19 | |
| 9 | 2022 | 18 | |
| 10 | 2004 | 16 | |
| 11 | 2003 | 15 | |
| 12 | 2023 | 9 | |
| 13 | 2018 | 8 | |
| 14 | 2022 | 7 | |
| 15 | 2023 | 4 |
About Fu‐Fei Hsu
Fu‐Fei Hsu is a scholar working on Molecular Biology, Immunology, Infectious Diseases, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 636 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Phagocytosis and Immune Regulation (3 papers), Signaling Pathways in Disease (2 papers), Viral gastroenteritis research and epidemiology (2 papers), RNA Interference and Gene Delivery (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Immunology (161 citations), Biomaterials (81 citations), Hepatology (42 citations), Infectious Diseases (87 citations) and Molecular Biology (316 citations). Fu‐Fei Hsu has collaborated with scholars based in Taiwan, Singapore and United States. Frequent co-authors include Yunching Chen, Yun‐Chieh Sung, Hsi‐Chien Huang, Yi-Hung Ou, Sheau-Yann Shieh, Han‐Chung Wu, Jian‐Tai Qiu, Kuan‐Wei Huang, Chu-Chi Lin and Yu-Chuan Shih. Their work appears in journals such as Journal of Biomedical Science, Hepatology, The EMBO Journal, Molecular Pharmaceutics and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.